State-of-the-art facilities

With our state-of-the-art biopharmaceutical laboratories and GMP facilities for the manufacture of monoclonal antibodies (mAbs) and the production of antibody-drug conjugates (ADCs) - up to Phase III clinical trials and early launches - in our campus in the Netherlands, our infrastructure is fully rigged up, positioning us to deliver on our ambitions.

Synthon Biopharmaceuticals' headquarters are located in Nijmegen, the Netherlands. This 36,000 mlocation accommodates research and development facilities. In addition, the site houses all responsibilities related to the core process: 

  • Strategic and project management for R&D activities
  • Intellectual property expertise
  • Regulatory affairs competence
  • Medical research & development
  • Business development

These activities are supported by a high-quality service organization, including Information Services, Finance & Accounting, Human Resources and Legal Affairs. The Nijmegen facility is home to approximately 300 employees.

Robust state-of-the-art infrastructure

In recent years Synthon Biopharmaceuticals has ramped up its investments in its biopharmaceutical infrastructure at its HQ campus in Nijmegen. We now have all the facilities necessary for process development right up to large-scale production. Infrastructure highlights include:

Synthon_Biopharmaceuticals_2-e3142b5d.jpg
Monoclonal antibody plant
  • ultramodern GMP plant for the production of therapeutic monoclonal antibodies (mAbs)
  • flexible multi-product plant 
  • manufacturing capability comprising dual 2,000L bioreactors based on single-use technologies
ADC_plant-57766dd4.jpg
Antibody-drug conjugation facility
  • acility includes high-potent clean room suite and supporting areas for buffer preparation and in-process control testing
  • inspected and approved by the Dutch authorities for manufacturing and release of ADC material and Investigational Medicinal Product for use in clinical programs
Thomas_de_Beijer-d5776196.jpg
Main R&D building
  • two floors each with 1,000 mof laboratory space
  • a total 2,400 moffice space, housing the majority of Biopharmaceuticals’ R&D staff
  • the building also contains 800 m2 GMP warehouse

Quality and compliance

We develop and use advanced analytical technologies to design efficient manufacturing processes and to deeply characterize and control our products from a chemical, physical and biological perspective. High-quality standards are enforced by bringing science and compliance closely together in our ultramodern manufacturing facilities and quality control laboratories.

Synthon Biopharmaceuticals has been certified by the Dutch Healthcare Inspectorate (IGZ) for the manufacturing, quality control testing and release of Investigational Medicinal Products.

Environment, health and safety

Synthon Biopharmaceuticals monitors the well-being of our employees and the EHS priority areas. We do our utmost to ensure that all our employees and contractors can return home safely and in good health. 

read more

Best Workplace

In 2017 and 2019, Synthon Nijmegen was named a Best Workplace® according to the Dutch Great Place to Work Institute®. In 2019, Synthon achieved an honorable 9th place in the list of Top 10 Best Multinational Workplaces in the Netherlands.  

M16_with_rooftop_garden-cfeb35ba.jpg
Where to find us

Synthon Biopharmaceuticals BV
Microweg 22
P.O. Box 7071
6503 GN Nijmegen, the Netherlands

(+31) 24 372 77 00
info@synthonbiopharmaceuticals.com

VAT number: NL8511.30.975.B.01
Chamber of Commerce: 54042577
 

Route description

     Share this page